Product information	»
Mode of action	»
Preclinical results	»
Clinical oncological effects	»
Frequently asked questions	»
References	»

Safety profile

Acute and subacute toxicology tests conducted under GLP circumstances revealed no definitive side effects, even for the highest dose ranges tested. The vast majority of reports contain no data about substantial side effects. In rare instances, side effects, if they occur, are mild and transient, namely: diarrhea, nausea, flatulence, soft stool, constipation, dizziness. Long-term administration of Aveamar results in increased body weight.

»	Review 1 The product and its registration status
»	Review 2 The Approved Avemar label

»	Product name
»	Composition
»	Indications
»	Mode of action
»	Preclinical anti-cancer effects
»	Clinical efficacy
«	Safety profile
»	Known interactions with other drugs
»	Warning
»	Preparation, dosage and administration

Home